News

US Pres. Biden: Reached goal of 200 million COVID-19 vaccine doses

US President Joe Biden announced that they have reached their goal of 200 million doses of coronavirus vaccines as of Wednesday, as reported by Reuters.

Additional takeaways

"US vaccination effort may have saved tens of thousands of lives."

"US still has a long way to go on vaccines."

"By Thursday, 80% of Americans over age 65 will have had at least one vaccine."

"There has been a dramatic decline in deaths of seniors in US."

"It is time to open up the new phase of US vaccination effort, targeting everyone over 16."

In a statement published simultaneously, "the US has administered 215,951,909 doses of COVID-19 vaccines in the country as of Wednesday morning and distributed 277,938,875 doses," the Centers for Disease Control and Prevention (CDC) noted.

Market reaction

The market mood remains upbeat following these remarks. As of writing, Wall Street's three main indexes were up between 0.75% and 0.45%.

 

Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.


RELATED CONTENT

Loading ...



Copyright © 2024 FOREXSTREET S.L., All rights reserved.